ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE backs selective internal radiation therapy for advanced liver cancer
March 03, 2021The UK’s National Institute for Health and Care Excellence (NICE) has recommended selective internal radiation therapy (SIRT) for the treatment of advanced liver cancer in final draft guidance. -
SIRT is better tolerated than sorafenib, but doesn’t increase overall survival in HCC
May 07, 2019Results of the SARAH trial demonstrate that SIRT resulted in median overall survival (OS) of 8.0 months compared to 9.9 months with sorafenib (p=0.179)…
Pharma Sources Insight January 2025
